FinalDose
PrivateLast Round
Accelerator
Mar 1, 2026
Est. Valuation
$1.79M
Total Funding Raised
$5.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
FinalDose is a biotechnology company developing a programmable drug platform that uses DNA recognition to find and destroy diseased cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FinalDose Comparables
Compare FinalDose with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoSenX | 78% | |
| SynsoryBio | 77% | |
| Granza Bio | 71% | |
FinalDose Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 1, 2026 |
FinalDose Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y Combinator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 2, 2026
Grew 120% QoQ, from 5 to 11 employees.
- Jul 21, 2026
Grew 80% QoQ from 5 to 9 employees.
FinalDose Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about FinalDose's valuation, stock price, and market status.